WeVote
Log In

Bill

Bill

A 4839

Requires DHS to submit Medicaid State plan amendment to federal government requesting approval to create Health Home Program for certain Medicaid beneficiaries with sickle cell disease.

2026-2027 Regular Session

The bill would require DHS to seek CMS approval to create a Medicaid Health Home Program for sickle cell patients, providing coordinated, comprehensive care.

Introduced, Referred to Assembly Aging and Human Services Committee
0
WeVote Research Nonpartisan
Bill Summary · A 4839

Summary: New Jersey Assembly Bill A-4839 (Session 222)

Title

Requires Department of Human Services (DHS) to submit Medicaid State Plan Amendment to the federal government requesting approval to create a Health Home Program for certain Medicaid beneficiaries with sickle cell disease.

Purpose and Intent

  • The bill directs New Jersey’s Department of Human Services to seek federal approval to establish a Health Home Program specifically for Medicaid beneficiaries who have sickle cell disease.
  • The overarching goal is to improve care coordination, care management, and integrated services for individuals with sickle cell disease who are enrolled in Medicaid, potentially reducing hospitalizations and improving quality of life.

Key Provisions and Changes

  • State Plan Amendment (SPA) Submission: Requires DHS to prepare and submit a Medicaid State Plan Amendment to the federal Centers for Medicare & Medicaid Services (CMS) seeking authorization to operate a Health Home Program targeted to a defined population: Medicaid beneficiaries with sickle cell disease.
  • Program Scope (Health Home Model): The Health Home Program would provide comprehensive care management and care coordination services. This typically includes:
    • Care coordination across outpatient and inpatient services
    • Health promotion and disease prevention
    • Medication management and reconciliation
    • 24/7 crisis support and access to primary and specialty care
    • Patient and caregiver education and support
    • Care planning and linkage to social services (housing, transportation, nutrition, etc.)
  • Target Population: Medicaid beneficiaries diagnosed with sickle cell disease. The bill may define criteria (e.g., age ranges, diagnostic codes) consistent with state or CMS definitions for health home eligibility, though the exact criteria would be refined in the SPA and subsequent regulations.
  • Administrative Authority: DHS is empowered to develop the SPA and to implement the Health Home Program once federal approval is obtained. The bill implies coordination with relevant state agencies, healthcare providers, and managed care organizations operating under New Jersey’s Medicaid program.
  • Compliance and Reporting: While not detailed in the action history, typical provisions would require adherence to CMS Medicaid Health Home regulations, program reporting, performance metrics, and annual waiver/SPA renewals or amendments as needed.

Who/What Would Be Affected

  • Medicaid Beneficiaries with Sickle Cell Disease: Primary recipients of the Health Home services, with potential improvements in access to coordinated care, reduced emergency department visits, and better health outcomes.
  • New Jersey Department of Human Services: Responsible for developing, submitting, and administering the SPA and the Health Home Program, including provider contracts, data collection, and program oversight.
  • Healthcare Providers and Care Teams: Primary care physicians, hematologists, nurse care managers, social workers, and other providers who would participate in care coordination and service delivery.
  • Medicaid Managed Care Organizations (MCOs): May engage as part of care coordination, member outreach, and service provision under the Health Home Model.

Procedural and Timeline Considerations

  • Introductory Status: Introduced and referred to the Assembly Aging and Human Services Committee (as of May 4, 2026).
  • Next Steps: The bill would proceed through committee review, potential amendments, and floor votes. If approved by the Legislature, it would require signature by the Governor to become law.
  • Federal Approval Dependency: Implementation hinges on CMS approval of the Medicaid SPA for a Sickile Cell Health Home Program. The timeline for federal review can vary; states typically work with CMS to finalize SPA terms, waivers, and any required state plan amendments.
  • Implementation Milestones (anticipated, if approved): Development of SPA language, provider network readiness, enrollment criteria set for beneficiaries, and establishment of care management protocols aligned with federal health home requirements.

Notes

  • The bill’s language, once the SPA is drafted, will specify eligibility criteria, funding mechanisms, capitation or service payment structures, and performance metrics.
  • The focus on sickle cell disease aligns with targeted care coordination strategies to address complex chronic conditions within the Medicaid program.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.